stars 1 stars 2 stars 3

Entos Pharmaceuticals Inc. is a clinical-stage genetic medicines company. A new reality in genetic medicine lies ahead, one that will be ushered in with the advent of safe, effective, and redosable nucleic acid delivery technologies. At Entos, we develop next generation genetic medicines using our proprietary Fusogenix proteolipid vehicle (PLV) drug delivery system. Fusogenix PLVs are formulated with FAST proteins to enable the delivery of nucleic acid into target cells through direct fusion.

Entos Pharmaceuticals Questions

The Entos Pharmaceuticals annual revenue was $18.6 million in 2026.

Arun Raturi is the CSO of Entos Pharmaceuticals.

24 people are employed at Entos Pharmaceuticals.

Entos Pharmaceuticals is based in Edmonton, Alberta.

The NAICS codes for Entos Pharmaceuticals are [5417, 325, 541711, 32, 541, 54171, 54].

The SIC codes for Entos Pharmaceuticals are [2834, 28, 283].

Top Entos Pharmaceuticals Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users